A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Clinical trial NCT00741234 · COMPLETED

Trial details

NCT number: NCT00741234
Sponsor: S*BIO
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Hematologic Malignancies Myelodysplastic Syndrome

Start date: 2007-04-01
Primary completion: 2012-03-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.